Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Ki8751 is a potent, orally available inhibitor of the kinase activity of VEGFR2 (IC50 = 0.9 nM).1 It less potently inhibits c-Kit, PDGRFα, and FGFR2 (IC50s = 40-170 nM) and has no significant effect against several other receptor tyrosine kinases. Ki8751 suppresses the growth of VEGF-stimulated human umbilical vein endothelial cells at nanomolar concentrations.1 It shows significant anti-tumor activity against assorted human tumor xenografts in nude mice.1 Ki8751 also induces cellular senescence in colorectal cancer cells.2
WARNING This product is not for human or veterinary use.
1. Novel potent orally active selective VEGFR-
2. Inhibition of VEGF induces cellular senescence in colorectal cancer cells. Int. J. Cancer 129(9), 2115-2123 (2011).